Navigation Links
Arthroscopy of the knee joint for arthrosis: No benefit detectable
Date:5/13/2014

interventions with strengthening exercises under the supervision of a physical therapist. There was no significant effect in the two outcomes "pain" and "global assessment of the symptoms" at any time point of the study. Hence the overall result is the same as in the preliminary report: The benefit of arthroscopy of the knee joint for the treatment of gonarthrosis is not proven.

Process of report production

IQWiG published the preliminary results in the form of the preliminary report in September 2013 and interested parties were invited to submit comments. At the end of the commenting procedure, the preliminary report was revised and sent as a final report to the commissioning agency in May 2014. The written comments submitted were published in a separate document at the same time as the final report. The report was produced in collaboration with external experts.

The executive summary provides an overview of the background, procedure and further results of the report.


'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New Mexico Orthopedic Specialist Dr. James Lubowitz was Selected to Lecture at the Arthroscopy Association of German Speaking Countries (AGA) on ACL Injuries in Skiers
2. Colorado Shoulder Specialist Dr. Peter J. Millett Selected as an Honorary Member of the German Arthroscopy Association (AGA)
3. Joint-Replacement Failure Rate Higher for Smokers: Studies
4. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
5. Obesity, Diabetes May Raise Complications After Joint Replacement
6. Oxford University Press acquires joint ownership of Journal of Surgical Case Reports
7. Joint Replacement Boosts Heart Attack Risk Right After Surgery: Study
8. Joint Commission certifies 2 Primary Stroke Centers at Penn Medicine
9. Joint EACPR and AHA statement empowers health care professional to use Clinical Cardiopulmonary Exercise Testing
10. No proof that patients lose weight after joint replacement surgery
11. Topical Products for Muscle, Joint Pain May Cause Burns: FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cuidado Casero ... and hospice, PCO, PCA, and PHC in Texas, New Mexico, ... a sponsor of the North Texas Chapter of PAM’s 2014 ... the Peruvian American Medical Society. The North Texas chapter was ... and other professionals interested in improving medical care for the ...
(Date:7/27/2014)... 2014 Hyaluronic Acid can hold 1,000 ... key to the power of Hyaluronic Serums. , "Hyaluronic ... founder of Sublime Beauty®. "But like collagen, it diminishes ... ours improves skin moisture-retention and radiance." , Hyaluronic ... a healthy and beautiful look. Key Ingredients in the ...
(Date:7/27/2014)... Detroit, MI (PRWEB) July 27, 2014 ... the public with organic ways to achieve a younger ... eye cream buyer's guide to help men and women ... . , The details that are presented in the ... range of price information for consumers. On drawback to ...
(Date:7/27/2014)... new pill-only antiviral drug regimens could provide shorter, more ... majority of patients infected with hepatitis C, even those ... two studies published in The Lancet . , ... is the most common genotype in the USA, Europe, ... the most difficult to treat. , Around 150 million ...
(Date:7/27/2014)... a powerful drug given at the time of a ... of rejection, but that it also allows a less ... the operation. , The key results are reported in ... Transplant Congress in San Francisco today. They will help ... combinations of treatments used to prevent early kidney rejection ...
Breaking Medicine News(10 mins):Health News:Cuidado Casero Sponsors Peruvian American Medical Society (PAMS) Gala 2Health News:Aging or Dry Skin Benefits from Hyaluronic Serum; Now 30% Off Sale at Sublime Beauty® 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 2Health News:The Lancet: New oral drug regimens cure hardest-to-treat hepatitis C 3Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 2Health News:Kidney transplant drug halves the early risk of rejection and allows less toxic treatment 3
... cause damage to the brain of youngsters, says a ... misuse can do to them. // ,Thomas Heffernan, ... students for the research presented at the British Psychological ... of Daily Mail. ,Half the students ...
... research team from the New York University College of Dentistry ... oral decay evolved along with its human hosts. ... common ancestor who lived in Africa between 100,000 and 200,000 ... by Page Caufield, a professor of cariology and comprehensive care ...
... in EMBO says that the parasite that is responsible ... new pathway. Sleeping sickness is caused by Trypanosoma brucei ... ,Shulamit Michaeli and colleagues describe a pathway in T. ... this pathway shuts down the synthesis of a crucial ...
... the healthcare sector with a super-specialty hospital in Gurgaon,// on ... of Rs.2.1 billion ($45 million). ,Christened Artemis Health ... will open next month. "In the second phase, another 240 ... of AHS. ,"This is the first of similar ...
... governments to join the anti-tuberculosis global plan, which would ... disease has become extremely drug-resistant. ,Ban's message ... on Saturday. The World Health Organization (WHO) recently reported ... of tuberculosis, XDR-TB, which threatens to derail efforts to ...
... be hampered if they indulge in excessive drinking.// This ... a psychologist from Northumbria University. ,Alcohol and ... young age which could extend into adulthood. According to ... a very crucial stage. ,Dr. Thomas Heffernan ...
Cached Medicine News:Health News:Tooth Decay Bacteria Evolved Along With Man 2
(Date:7/28/2014)... Germany and LONDON , ... , Collaboration aims to create and commercialize companion diagnostic ... use of IRESSA  for non-small cell lung cancer patients  ... FDA-approved  therascreen   EGFR test and is planned to run on Rotor-Gene ... Project enabled by AstraZeneca master framework agreement ...
(Date:7/25/2014)... July 25, 2014  In today,s marketplace, launching multiple ... challenging - as is managing a portfolio of products ... it possible - or even preferable - to pool ... can you combine resources and activities, and what marketing ... These are just a few of the dilemmas facing ...
(Date:7/25/2014)... 25, 2014 /PRNewswire-iReach/ -- Full Service CRO ... new Vice President of Business Development. Peter has been ... a number of different business development positions with some ... were primarily related to business development/sales management and marketing.  ... years makes him a key and strategic asset to ...
Breaking Medicine Technology:QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
... FALLS, N.J., Dec. 22, 2010 Regenicin, Inc. (OTC Bulletin ... the development of regenerative cell therapies to restore the health ... Annual OneMedForum on January 11-13, 2011 in San Francisco. Randall ... and business model for bringing new regenerative medicine products to ...
... MiMedx Group, Inc. (OTC Bulletin Board: ... patent protected biomaterial-based products, announced today that it has ... leader in the development of tissue processing techniques for ... amnion membranes. Privately held Surgical Biologics was ...
Cached Medicine Technology:Regenicin CEO to Present at OneMedForum Business Development and Finance Conference 2MiMedx Announces Agreement to Acquire Surgical Biologics 2MiMedx Announces Agreement to Acquire Surgical Biologics 3MiMedx Announces Agreement to Acquire Surgical Biologics 4MiMedx Announces Agreement to Acquire Surgical Biologics 5
Small, removable blades, length 178 mm, (7"). Function: tissue retracting....
Toothed Pituitary Rongeurs, 12 300 mm....
Ferris Smith Rongeurs, 12 overall length 300 mm....
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
Medicine Products: